Sanofi Says Amgen Patents Doomed Despite Jury Win
A jury's finding that two Amgen patents for a cholesterol drug were valid can't stand, rival Sanofi told a Delaware federal court in a motion Friday, saying the claims of the...To view the full article, register now.
Already a subscriber? Click here to view full article